Skip to main content

Implementation of a Leadership Development Programme for Renal Network Leaders with NHS England to support renal service transformation

A Collaborative Working Project between Boehringer Ingelheim Limited (BIL) and NHS England (NHSE) and implemented through the Faculty of Medical Leadership Management (FMLM), aims to co-create and deliver a leadership development programme for clinical leaders across the Renal Networks in England as they embark on transforming local renal disease services. 

NHSE established a programme in early 2021 to integrate renal care across health care systems, with a key element - the further development of the Renal Networks. Local clinical leadership is core to the delivery of the networks and required across all pathways related to kidney disease.  There has been a recognised requirement to support this with clinical leadership development.

The specific objectives of this collaboration are:

  • To work with NHSE and the FMLM to identify and co-design a programme to support the newly established Renal Network clinical leaders in order to achieve the aims of the NHS Long Term Plan, and to deliver the Renal Network specification.
  • To identify the key skills and learning needs for clinical leads, which will enable them to operate and influence across their wider peer group and system.
  • Provide opportunities for clinical peer support and learning
  • Provide and facilitate an awareness of wider population health, inequalities in outcomes, experience, and access
  • By taking a population health approach and evaluating the impact of service transformation create the opportunity to deliver increased productivity and value for money thereby establishing a sustainable model

The project is scheduled to commence January 2024 and is anticipated to complete by end of December 2024.

Boehringer Ingelheim Limited is pleased to collaborate with NHSE and the FMLM to implement a  Clinical Leadership development programme for the clinical leaders of the Renal Networks to support the transformation of renal services.

 

NP-GB-104082   December 2023